Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin

REFERENCES

• Gruen RL, Pitt V, Green S, Parkhill A, Campbell D, Jolley D. The effect of provider case volume on cancer mortality: systematic review and meta-analysis. CA Cancer J Clin 2009;59(3):192–211.
   PubMed Web of Science ®Google Scholar
• Köhne CH, Lenz HJ. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer. Oncologist 2009;14(5):478–488.
   PubMed Web of Science ®Google Scholar
• Calviello G, Serini S, Piccioni E, Pessina G. Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 2009;61(3):287–301.
   PubMed Web of Science ®Google Scholar
• Sinkovics JG, Horvath JC. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Arch Immunol Ther Exp (Warsz) 2008;56(Suppl 1):3s–59s.
   PubMedGoogle Scholar
• Goel A, Jhurani S, Aggarwal BB. Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res 2008;52(9):1010–1030.
   PubMed Web of Science ®Google Scholar
• Chiu TL, Su CC. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. Int J Mol Med 2009;23(4):469–475.
   PubMed Web of Science ®Google Scholar
• Harikumar KB, Kuttan G, Kuttan R. Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products—berberine, curcumin and picroliv. J Exp Ther Oncol 2008;7(4):275–284.
   PubMedGoogle Scholar
• William BM, Goodrich A, Peng C, Li S. Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia. Hematology 2008;13(6):333–343.
   PubMed Web of Science ®Google Scholar
• Yang PC, Xing Z, Berin CM, Soderholm JD, Feng BS, Wu L, Yeh C. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 2007;133(5):1522–1533.
   PubMed Web of Science ®Google Scholar
• Tu YH, Oluwole C, Struiksma S, Perdue MH, Yang PC. Mast cells modulate transport of CD23/IgE/antigen complex across human intestinal epithelial barrier. North Am J Med Sci 2009;1(1):16–24.
   Google Scholar
• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Jr. Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69(4):491–497.
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002;2:862–871.
   PubMed Web of Science ®Google Scholar
• Walsh D, Mahmoud F, Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 2003;11:60–62.
   PubMed Web of Science ®Google Scholar
• Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, Baracos VE. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 2009;89(4):1173–1179.
   PubMed Web of Science ®Google Scholar
• Johnson G, Sallé A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud JP, Malthièry Y, Simard G, Ritz P. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 2008;24(5):443–450.
   PubMed Web of Science ®Google Scholar
• Lelbach A, Muzes G, Feher J. Current perspectives of catabolic mediators of cancer cachexia. Medical Science Monitor 2007;13:RA168–RA173.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 2008;8(13–14):1767–1772.
   PubMed Web of Science ®Google Scholar
• Villegas I, Sánchez-Fidalgo S, Alarcón ?, de la Lastra C. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res 2008;52(9):1040–1061.
   PubMed Web of Science ®Google Scholar
• Teodoro JG, Parker AE, Zhu X, Green MR. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science 2006;313:968–971.
   PubMed Web of Science ®Google Scholar
• Phillips DC, Garrison SP, Jeffers JR, Zambetti GP. Assays to measure p53-dependent and -independent apoptosis. Methods Mol Biol 2009;559:143–159.
   PubMedGoogle Scholar